These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 748781

  • 1. An animal model for the study of prostate carcinoma.
    Lubaroff DM, Canfield L, Rasmussen GT, Reynolds CW.
    Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
    [Abstract] [Full Text] [Related]

  • 2. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM, Culp DA.
    Trans Am Assoc Genitourin Surg; 1977 Dec; 69():72-7. PubMed ID: 617916
    [Abstract] [Full Text] [Related]

  • 3. R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer.
    Lubaroff DM, Canfield L, Feldbush TL, Bonney WW.
    J Natl Cancer Inst; 1977 Jun; 58(6):1677-89. PubMed ID: 864747
    [Abstract] [Full Text] [Related]

  • 4. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT, Yu GW, Coffey DS.
    Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
    [Abstract] [Full Text] [Related]

  • 5. The Dunning tumors.
    Lubaroff DM, Canfield L, Reynolds CW.
    Prog Clin Biol Res; 1980 Jul; 37():243-63. PubMed ID: 6247719
    [Abstract] [Full Text] [Related]

  • 6. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA.
    Cancer Res; 1992 May 15; 52(10):2916-22. PubMed ID: 1581909
    [Abstract] [Full Text] [Related]

  • 7. Histology and ultrastructure of the R-3327 C-F transplantable prostate tumor of Cophenhagen-Fisher rats.
    Seman G, Myers B, Bowen JM, Dmochowski L.
    Invest Urol; 1978 Nov 15; 16(3):231-6. PubMed ID: 711418
    [Abstract] [Full Text] [Related]

  • 8. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS, Ahluwalia R, Zhang X, Conrad H, Emmanouilides C.
    Int J Oncol; 2003 Dec 15; 23(6):1569-74. PubMed ID: 14612928
    [Abstract] [Full Text] [Related]

  • 9. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.
    Cancer Res; 2001 Mar 01; 61(5):2239-49. PubMed ID: 11280793
    [Abstract] [Full Text] [Related]

  • 10. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 11. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
    Coffey DS, Smolev J, Heston WD, Scott WW.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):289-91. PubMed ID: 748782
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ, Pollack A, Malinin T, Block NL, Irvin GL.
    J Natl Cancer Inst; 1982 Jul 15; 69(1):79-87. PubMed ID: 6954325
    [Abstract] [Full Text] [Related]

  • 13. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
    Halin S, Wikström P, Rudolfsson SH, Stattin P, Doll JA, Crawford SE, Bergh A.
    Cancer Res; 2004 Aug 15; 64(16):5664-71. PubMed ID: 15313905
    [Abstract] [Full Text] [Related]

  • 14. A novel immunological model for the study of prostate cancer.
    Sharma N, Luo J, Kirschmann DA, O'Malley Y, Robbins ME, Akporiaye ET, Lubaroff DM, Heidger PM, Hendrix MJ.
    Cancer Res; 1999 May 15; 59(10):2271-6. PubMed ID: 10344727
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK, Heston WD, Scott WW, Coffey DS.
    Cancer Treat Rep; 1977 May 15; 61(2):273-87. PubMed ID: 872132
    [Abstract] [Full Text] [Related]

  • 16. Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate.
    Bosland MC, Prinsen MK, Dirksen TJ, Spit BJ.
    Cancer Res; 1990 Feb 01; 50(3):700-9. PubMed ID: 2105161
    [Abstract] [Full Text] [Related]

  • 17. The Nb rat prostatic adenocarcinoma model system.
    Drago JR, Goldman LB, Maurer RE.
    Prog Clin Biol Res; 1980 Feb 01; 37():265-91. PubMed ID: 7384086
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec 01; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 19. Characterization of prostate carcinoma lines in the Copenhagen rat.
    Voigt W, Lopez DM.
    Natl Cancer Inst Monogr; 1978 Dec 01; (49):269-73. PubMed ID: 748780
    [Abstract] [Full Text] [Related]

  • 20. Animal model of human disease: metastic adenocarcinoma of the prostate.
    Pollard M.
    Am J Pathol; 1977 Jan 01; 86(1):277-80. PubMed ID: 831516
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.